Clinical trial
Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury
NCT05084196 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melatonin for the Prevention of Antibiotic Associated Acute Kidney Injury
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- June 5, 2023
- Completion date
- December 31, 2027
- Enrollment
- 300 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute kidney injury, adverse drug event